I wonder if the people writing and pushing stories like this…
THE PAST DECADE has been a public relations nightmare for big pharmaceutical companies – and deservedly so, their critics say. Activists and non-government organisations the world over have slated Big Pharma for putting profits ahead of people and vigorously enforcing their intellectual property rights, preventing many from gaining access to life-saving medication. It’s an ugly story told repeatedly – in the media, over dinner, at AIDS conferences and during university seminars – and it has earned the pharmaceutical industry an unmatched notoriety.
… ever have an inkling that their efforts are connected to these effects:
A growing shortage of medications for a host of illnesses – from cancer to cystic fibrosis to cardiac arrest – has hospitals scrambling for substitutes to avoid patient harm, and sometimes even delaying treatment.
What do people think is going to happen when the engines of pharmaceutical production are continuously bullied in the press and slowly but forcefully squeezed by governments the world 'round to gradually strangle themselves, by cutting prices or giving away drugs or releasing claim to patents, and to scrimp and otherwise curtail long established business models, all to please an increasingly unpleasable, faceless, and voracious collective? Should anyone be surprised that businesses under seige might have to pull back and be smaller businesses, giving up that territory which they cannot hold without risk of doing themselves greater damage?
Some experts pointedly note that pricier brand-name drugs seldom are in short supply. The Food and Drug Administration agrees that the overarching problem is that fewer and fewer manufacturers produce these older, cheaper generic drugs, especially the harder-to-make injectable ones. So if one company has trouble – or decides to quit making a particular drug – there are few others able to ramp up their own production to fill the gap
In other words, business that produces profits continues. That which doesn't, doesn't.
And plainly, either there isn't enough demand to sustain "these older, cheaper generic drugs", OR there is plenty of demand but prices are constrained in some arbitrary manner that effectively negates the demand, making it worth nobody's while to go to the trouble to satisfy it.
And there is no sign that the collectivists who have slowly been running the pharmaceutical industry into the ground have any intention of wising up and backing off. Shortages and associated dislocations will increase in number and severity, and the pinheads will scream louder and longer that more needs to be done, choking themselves and their fellows with their own dim furies.
Relatedly, today at Mises: How the Experts Are Wrecking Healthcare
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 | ||||||